Joint Rapid Outbreak Assessment: Multi-country outbreak of Salmonella Agona infections linked to infant formula
This document provides an assessment of the public health risk associated with a multi-country outbreak of Salmonella Agona associated with consumption of potentially contaminated infant formula from France.
Rapid risk assessment: Multiple reports of locally-acquired malaria infections in the EU
In the context of five recent events of local malaria transmission in the EU, we assess the risk of malaria spread in the EU.
Rapid Outbreak Assessment: Multi-country outbreak of new Salmonella enterica 11:z41:e,n,z15 infections associated with sesame seeds, 14 June 2017
An outbreak of a new serovar of Salmonella enterica subspecies enterica affected 47 individuals in five European Union countries between March 2016 and May 2017.
Rapid Risk Assessment: Cluster of new Salmonella serotype cases in four EU Member States, 20 March 2017
Since March 2016, four EU Member States have reported a total of 40 cases of a new Salmonella serotype. This risk assessment discusses the suspected vehicle of infection and assesses the threat to public health in the EU/EEA.
Risk assessment: Epidemiological situation of West Nile virus infection in the European Union - Update, 13 July 2012
On 7 and 10 July, the Hellenic Centre for Disease Control and Prevention (KEELPNO) reported the first two human cases of West Nile virus (WNV) infection in Greece this year. When looking at the epidemiology of WNV infection in Greece since 2010, one can observe a progressive geographical expansion of WNV transmission throughout the country. For this reason, these newly confirmed cases in Athens do not come unexpected.
Joint ECDC and EMCDDA rapid risk assessment: HIV in injecting drug users in the EU/EEA, following a reported increase of cases in Greece and Romania
Most European countries reported no changes in the rate of newly diagnosed cases of HIV or HIV prevalence in IDU in 2011.
Rapid risk assessment: Update on autochthonous Plasmodium vivax malaria in Greece
The ECDC risk, as assessed on 23 August 2011, remains unchanged. The main risk is to persons residing in, visiting and working in the affected areas of Greece, particularly Evrotas in Lakonia. The risk for further extension of malaria transmission into the EU as a result of this event is considered low at present. EU national blood competent authorities should be considering whether to implement deferral measures for persons returning from these specific affected areas in Greece, taking into consideration measures currently implemented by the Greek blood safety authorities and after a considered risk assessment in collaboration with their national public health authorities.
Risk assessment: Autochthonous Plasmodium vivax malaria in Greece
Greece reports six cases of Plasmodium vivax infection in Evrotas, Lakonia, Peloponnese region, and Chalkida in Evoia since June 2011. The main risk related to the current event is to persons living in, visiting and working in the particular area of Evrotas in the district of Lakonia (and potentially Chalkida in Evoia, though more information is needed) in Greece.